MyJournals Home  

RSS FeedsPhase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer (British Journal of Cancer)

 
 

17 january 2019 23:00:11

 
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer (British Journal of Cancer)
 




 
90 viewsCategory: Oncology
 
HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma (British Journal of Cancer)
Publisher Correction: Expanding the search (Nature Reviews Cancer)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten